EUVIMEDEUVIMED entdecken
ValidierungsstudieEvaluationsstudie

Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci

Axel Philip, Saoussen Oueslati, Francesco Villa, Christophe Pannetier, Vincent Cattoir iD, Jacques Duranteau, Samy Figueiredo, Thierry Naas iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae062 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Axel Philip und 7 weiteren Autor:innen. Beteiligte Einrichtung: Team ReSIST, INSERM U1184, Faculty of Medicine Université Paris-Saclay, LabEx LERMIT, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France. Hauptthemen laut MEDLINE: Sensitivity and Specificity, Real-Time Polymerase Chain Reaction, Vancomycin Resistance, Vancomycin-Resistant Enterococci. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

VRE are increasingly described worldwide. Screening of hospitalized patients at risk for VRE carriage is mandatory to control their dissemination. Here, we have developed the Bfast [VRE Panel] PCR kit, a rapid and reliable quantitative PCR assay for detection of vanA, vanB, vanD and vanM genes, from solid and liquid cultures adaptable to classical and ultrafast real-time PCR platforms.

Methods

Validation was carried out on 133 well characterized bacterial strains, including 108 enterococci of which 64 were VRE. Analytical performances were determined on the CFX96 Touch (Bio-Rad) and Chronos Dx (BforCure), an ultrafast qPCR machine. Widely used culture plates and broths for enterococci selection/growth were tested.

Results

All targeted van alleles (A, B, D and M) were correctly detected without cross-reactivity with other van genes (C, E, G, L and N) and no interference with the different routinely used culture media. A specificity and sensitivity of 100% and 99.7%, respectively, were determined, with limits of detection ranging from 21 to 238 cfu/reaction depending on the targets. The Bfast [VRE Panel] PCR kit worked equally well on the CFX and Chronos Dx platforms, with differences in multiplexing capacities (five and four optical channels, respectively) and in turnaround time (45 and 16 minutes, respectively).

Conclusions

The Bfast [VRE Panel] PCR kit is robust, easy to use, rapid and easily implementable in clinical microbiology laboratories for ultra-rapid confirmation of the four main acquired van genes. Its features, especially on Chronos Dx, seem to be unmatched compared to other tools for screening of VRE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sensitivity and SpecificityReal-Time Polymerase Chain ReactionVancomycin ResistanceVancomycin-Resistant EnterococciHumansEnterococcusGram-Positive Bacterial InfectionsBacterial ProteinsTime FactorsGenes, Bacterial

Substanzen

Bacterial Proteins

Autor:innen und Institutionen

  • Team ReSIST, INSERM U1184, Faculty of Medicine Université Paris-Saclay, LabEx LERMIT, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France.
  • R&D, BforCure, 14 rue de la Beaune, 93100 Montreuil, France.
  • Bacteriology-Hygiene Department, Bicêtre Hospital, Assistance Publique/Hôpitaux de Paris, 94270 Le Kremlin-Bicêtre, France.
  • Department of Clinical Microbiology and French National Reference Centre for Antibiotic Resistance (Lab Enterococci), Rennes University Hospital, 35033 Rennes, France.
  • Surgical Intensive Care Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, 94270 Le Kremlin-Bicêtre, France.

ORCID-Profile: Vincent Cattoir, Thierry Naas

Zitieren

APA

Philip, A., Oueslati, S., Villa, F., Pannetier, C., Cattoir, V., Duranteau, J., Figueiredo, S., & Naas, T. (2024). Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae062

Vancouver

Philip A, Oueslati S, Villa F, Pannetier C, Cattoir V, Duranteau J, et al. Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae062

BibTeX
@article{Philip2024,
  author = {Philip, Axel and Oueslati, Saoussen and Villa, Francesco and Pannetier, Christophe and Cattoir, Vincent and Duranteau, Jacques and Figueiredo, Samy and Naas, Thierry},
  title = {Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae062}
}
Kostenlos starten →